Revenio to acquire Oculo for $14m.

Revenio, a Finnish ophthalmic diagnostics company, agreed to acquire Oculo, an Australian teleophthalmology and clinical communication platform firm, for $14m. “Software technology solutions are significantly enhancing patient eye care pathways and the clinical processes of eye care professionals. There are tremendous opportunities in improving the productivity and quality of eye care, and we see improving the continuum of care through secure communications and teleophthalmology with Oculo as a key," Jouni Toijala, Revenio CEO.